Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase

Neurosci Lett. 2016 Jan 1:610:48-53. doi: 10.1016/j.neulet.2015.10.049. Epub 2015 Oct 28.

Abstract

The present study aimed to investigate the involvement of the NMDA receptor (NMDAR) and/or nitric oxide (NO) pathway in ketamine-induced behavioral sensitization. Mice received repeated subcutaneous administration of ketamine (25mg/kg), once daily or once weekly for a total of five doses. Even three administrations of ketamine, daily or weekly, induced a rapid increase in locomotor activity in wild-type (WT), but not in GluN2D knockout (GluN2D-KO) mice. Furthermore, for WT mice receiving daily ketamine, elevated locomotor activity was maintained after a 1-month withdrawal period; however, this was not the case when ketamine was administered weekly. The effect of acute ketamine on nNOS activities was estimated with nicotinamide adenine dinucleotide hydrogen phosphate-diaphorase (NADPH-d) histochemistry. Ketamine rapidly increased the number of NADPH-d activated cells and strongly stained dendrites in the dorsal striatum and prefrontal cortex of WT mice, but not GluN2D-KO mice. These results suggest that ketamine-induced locomotor sensitization and nNOS activation in the frontal cortex-striatum neuronal circuit are positively correlated and that the NMDAR GluN2D subunit plays an important role in the acquisition and maintenance of ketamine-induced behavioral sensitization.

Keywords: GluN2D; Ketamine; Knockout; Neuronal nitric oxide synthase; Sensitization.

MeSH terms

  • Animals
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Enzyme Activation
  • Ketamine / pharmacology*
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Motor Activity / drug effects*
  • NADP / metabolism
  • Neurons / metabolism
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase Type I / metabolism*
  • Organ Specificity
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / metabolism
  • Protein Subunits / metabolism
  • Psychotropic Drugs / pharmacology*
  • Receptors, N-Methyl-D-Aspartate / genetics
  • Receptors, N-Methyl-D-Aspartate / metabolism*

Substances

  • NR2D NMDA receptor
  • Protein Subunits
  • Psychotropic Drugs
  • Receptors, N-Methyl-D-Aspartate
  • Nitric Oxide
  • NADP
  • Ketamine
  • Nitric Oxide Synthase Type I